These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38497568)

  • 1. Protracted fibrinolysis resistance following cardiac surgery with cardiopulmonary bypass: A prospective observational study of clinical associations and patient outcomes.
    Coupland LA; Pai KG; Pye SJ; Butorac MT; Miller JJ; Crispin PJ; Rabbolini DJ; Stewart AHL; Aneman A
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):772-780. PubMed ID: 38497568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
    Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
    Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study.
    Coupland LA; Rabbolini DJ; Schoenecker JG; Crispin PJ; Miller JJ; Ghent T; Medcalf RL; Aneman AE
    Crit Care; 2023 Feb; 27(1):55. PubMed ID: 36765421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.
    Tang M; Wierup P; Rea CJ; Ingerslev J; Hjortdal VE; Sørensen B
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):295-302. PubMed ID: 27607599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
    Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
    BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-test.
    Dibiasi C; Ulbing S; Bancher-Todesca D; Ulm M; Gratz J; Quehenberger P; Schaden E
    Br J Anaesth; 2024 Feb; 132(2):343-351. PubMed ID: 37925268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of dynamic cell-free DNA elevation during cardiac surgery with cardiopulmonary bypass.
    Ishay SY; Abu-Tailakh M; Raichel L; Hershenhoren TF; Matsa M; Lev-Ran O; Gideon S; Douvdevani A
    PLoS One; 2022; 17(10):e0276443. PubMed ID: 36301964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
    Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue near infra red spectroscopy change is not correlated with patients' outcome in elective cardiac surgery.
    Morel J; Bouchet JB; Vola M; Béraud AM; Clerc M; Awad S; Auboyer C; Molliex S
    Acta Anaesthesiol Scand; 2014 Aug; 58(7):835-42. PubMed ID: 24849868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial.
    Jiménez JJ; Iribarren JL; Brouard M; Hernández D; Palmero S; Jiménez A; Lorente L; Machado P; Borreguero JM; Raya JM; Martín B; Pérez R; Martínez R; Mora ML
    J Cardiothorac Surg; 2011 Oct; 6():138. PubMed ID: 21999189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study.
    Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA
    Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy.
    Paparella D; Parolari A; Rotunno C; Vincent J; Myasoedova V; Guida P; De Palo M; Margari V; Devereaux PJ; Lamy A; Alamanni F; Yusuf S; Whitlock R
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):35-44. PubMed ID: 28683994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated preoperative serum asymmetrical dimethylarginine (ADMA) is associated with poor outcomes after pediatric cardiac surgery.
    Hassinger AB; Wainwright MS; Lane JC; Haymond S; Backer CL; Wald E
    Intensive Care Med; 2012 Oct; 38(10):1697-704. PubMed ID: 22875338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.
    Gibbison B; Villalobos Lizardi JC; Avilés Martínez KI; Fudulu DP; Medina Andrade MA; Pérez-Gaxiola G; Schadenberg AW; Stoica SC; Lightman SL; Angelini GD; Reeves BC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013101. PubMed ID: 33045104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
    Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.
    Jimenez JJ; Iribarren JL; Lorente L; Rodriguez JM; Hernandez D; Nassar I; Perez R; Brouard M; Milena A; Martinez R; Mora ML
    Crit Care; 2007; 11(6):R117. PubMed ID: 17988379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of goal-directed therapy bundle based on PiCCO parameters to the prevention and treatment of acute kidney injury in patients after cardiopulmonary bypass cardiac operation: a prospective observational study].
    Pan C; Liu J; Hu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):731-736. PubMed ID: 31315732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ; Chandler WL
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Prolonged ICU Stay in Cardiac Surgery Patients as a Useful Method to Identify Nutrition Risk in Cardiac Surgery Patients: A Post Hoc Analysis of a Prospective Observational Study.
    Stoppe C; Ney J; Lomivorotov VV; Efremov SM; Benstoem C; Hill A; Nesterova E; Laaf E; Goetzenich A; McDonald B; Peine A; Marx G; Fehnle K; Heyland DK
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):768-779. PubMed ID: 30506711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.